The threat of Chagas' disease in transfusion medicine: The presence of antibodies to Trypanosoma cruzi in the US blood supply

Laboratory Medicine

Volumn 28, Issue 4, 1997, Pages 269-274

  Pan, Alfred A ^a,b   Winkler, Martin A ^a  

^a ABBOTT LABORATORIES   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOON ANTIBODY;

ARTICLE; BLOOD BANK; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CHAGAS DISEASE; DISEASE TRANSMISSION; HUMAN; RED CROSS; TRYPANOSOMA CRUZI; UNITED STATES;

EID: 0030903932     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1093/labmed/28.4.269     Document Type: Article

References (32)

1. World Health Organization. Control of Chagas disease. Report of a WHO Expert Committee. WHO Technical Report Series 811. Switzerland, World Health Organization; 1991:1-95.
2. Herwaldt BL, Juranek DD. Laboratory-acquired malaria, leishmaniasis, trypanosomiasis, and toxoplasmosis. Am J Trop Med Hyg. 1992;48:313-323.
3. Gudino MD, Linares J. Chagas' disease and blood transfusion. In: Westphal RG, Carlson KB, Turc JM, eds. Emerging Global Patterns in Transfusion-Transmitted Infections. Arlington, Va: American Association of Blood Banks. 1990;65-86.
4. Pan SC. Establishment of clones of Trypanosoma cruzi and their characterization in vitro and in vivo. Bull World Health Organ. 1982;60:101-107.
5. Kirchhoff LV, Neva FA. Chagas' disease in Latin American immigrants. JAMA. 1985;254:3058-3060.
6. Kirchhoff LV. American trypanosomiasis (Chagas' disease): a tropical disease now in the United States. N Engl J Med. 1993;329:639-644.
7. Schmunis GA. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion. 1991;31:547-557.
8. Pehrson P-O, Wahlgren M, Bengtsson E. Asymptomatic congenital Chagas' disease in a 5-year-old child. Scand J Infect Dis. 1981;13:307-308.
9. Villalba R, Fornes G, Alvarez MA, et al. Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report. Clin Infect Dis. 1992;14:594-595.
10. Schipper H, McClarty BM, McRuer KE, Nash RA, Penney CJ. Tropical diseases encountered in Canada: 1-Chagas' disease. Can Med Assoc J. 1980;122:165-172.
11. Hagar JM, Rahimtoola SH. Chagas' heart disease in the United States. N Engl J Med. 1991;325:763-768.
12. Diaz JCP, Brener S. Chagas' disease and blood transfusion. Mem Inst Oswaldo Cruz. 1984; 79(suppl):139-147.
13. Grant IH, Gold JWM, Wittner M, et al. Transfusion-associated acute Chagas' disease acquired in the United States. Ann Intern Med. 1989;111:849-851.
14. Nickerson P, Orr P, Schroeder M-L, Sekla L, Johnston JB. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med. 1989;111:851-853.
15. Wendel S. Chagas' disease: an old entity in new places. Int J Artif Organ. 1993;16:117-119.
16. Cimo PL, Luper WE, Scourus MA. Transfusion-associated Chagas' disease in Texas: report of a case. Tex Med. 1993;89:48-50.
17. Geisler PJ, Ito JI, Tegtmeier BR, Kerndt PR, Krance R. Fulminant Chagas' disease in bone marrow transplantation. Program and Abstracts of the 1987 Interscience Conference on Antimicrobial Agents and Chemotherapy. 1987;418:169. Abstract.
18. Schmunis GA. Chagas' disease and blood transfusion. .In: Dodd RY, Baker LF, eds. Infection, Immunity and Blood Transfusion. New York, NY: Alan R. Liss; 1985:127-145.
19. Brashear RJ, Winkler MA, Schur JD, et al. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I. Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T cruzi. Transfusion. 1995;35:213-218.
20. Winkler MA, Brashear RJ, Hall HJ, Schur JD, Pan AA. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II. Evaluation of a supplemental enzyme immunoassay and radioimmunoprecipitation assay for confirmation of serore-activity. Transfusion. 1995;35:219-225.
21. Kerndt P, Waskin HA, Kirchhoff LV, et al. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion. 1991;31:814-818.
22. Clark C. California center routinely screens for Chagas-causing parasite. Blood Weekly. November 13, 1995;8-9.
23. Rios M, Khabbaz RF, Kaplan JE, et al. Transmission of human T cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I-screened blood products. J Infect Dis. 1994;170:206-210.
24. Skolnick A. Does influx from endemic areas mean more transfusion-associated Chagas' disease? JAMA. 1989;262:1433.
25. Shulman IA. Preventing transfusion-transmitted Chagas' disease: The Los Angeles County/University of Southern California experience. Presented at the 1995 NIH Consensus Development Conference: Infectious Disease Testing for Blood Transfusions; Bethesda, Md, 1995:95-99.
26. Leiby DA, Lenes BA, Nystrom SR, et al. Seroprevalence of Trypanosoma cruzi in blood donors from metropolitan Miami. Transfusion. 1995;35(10 suppl):64S:S254.
27. Dodd RY. Preventing transfusion-transmitted Chagas' disease: The American Red Cross Approach. Presented at the 1995 NIH Consensus Development Conference. Infectious Disease Testing for Blood Transfusions; Bethesda Md, 1995:101-102.
28. Read EJ, Leiby DA, Pan AA, Stumpf RJ, Dodd RY. Evaluation of blood donor screening strategies for Trypanosoma cruzi in Los Angeles. Transfusion. 1995;35(10 suppl):40S:S157.
29. Anonymous. Blood Products Advisory Committee Address CJD, HIV-1 Antigen Testing and Chagas Disease. Council of Community Blood Centers Newsletter. December 15/22; 1995:1-5.
30. Appleman MD, Shulman IA, Saxena S, Kirchhoff LV. Use of a questionnaire to identify potential blood donors at risk for infection in California blood donors. Transfusion. 1993;33:61-64.
31. Galel SA, Kirchhoff LV. Risk factors for Trypanosoma cruzi infection in California blood donors. Transfusion. 1996;36:227-231.
32. Rock A. America's dangerous blood supply. Money. 1994;23:135-147.